Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of IL-28 and IL-29 to treat cancer and autoimmune disorders

Use of IL-28 and IL-29 to treat cancer and autoimmune disorders

US Patent 7351689 · Granted Apr 1, 2008

Estimated economic value: $3,428,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination of TIM-4 antagonist and PD-1 antagonist and methods of use2025
Compositions and methods for modified b cells expressing reassigned biological a2024
Combination of TIM-4 antagonist and PD-1 antagonist and methods of use2022
Compositions and methods including cytotoxic B lymphocyte cell line expressing e2021
Systems, devices and methods for monitoring breastfeeding2020
Compositions and methods for modified B cells expressing reassigned biological a2020
Systems, devices and methods for monitoring breastfeeding2020
Compositions and methods for modified B cells expressing reassigned biological a2020
Compositions and methods including cytotoxic B lymphocyte cell line expressing e2019
B7 family member zB7H6 and related compositions and methods2018
Gastrointestinal device with associated commensal microbes2018
Gastrointestinal device with associated microbe-promoting agents2018